Picard Medical, Inc. (AMEX: PMI) Stock Competitors & Peer Comparison
See PMI's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PMI and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PMI | $3.43 | -5.64% | 349.2M | -2.83 | -$1.20 | N/A |
| ABT | $107.81 | -0.14% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $339.03 | +0.47% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $87.16 | +1.44% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $49.31 | +0.02% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $89.72 | +0.45% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $84.75 | +2.08% | 32B | 36.37 | $2.33 | N/A |
| RMD | $211.94 | -5.06% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.73 | +1.52% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
PMI vs ABT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ABT trades at $107.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ABT's P/E ratio is 20.69. In terms of profitability, PMI's ROE is +4.99%, compared to ABT's ROE of +0.11%. Regarding short-term risk, PMI is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
PMI vs BSX-PA Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, PMI's ROE is +4.99%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, PMI is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
PMI vs SYK Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SYK has a market cap of 130B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SYK trades at $339.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SYK's P/E ratio is 25.32. In terms of profitability, PMI's ROE is +4.99%, compared to SYK's ROE of +0.16%. Regarding short-term risk, PMI is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SYK's competition here
Medtronic plc (NYSE: MDT)
PMI vs MDT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while MDT trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas MDT's P/E ratio is 15.76. In terms of profitability, PMI's ROE is +4.99%, compared to MDT's ROE of +0.10%. Regarding short-term risk, PMI is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
PMI vs BSX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BSX trades at $49.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BSX's P/E ratio is 15.91. In terms of profitability, PMI's ROE is +4.99%, compared to BSX's ROE of +0.15%. Regarding short-term risk, PMI is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
PMI vs EW Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while EW trades at $89.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas EW's P/E ratio is 33.23. In terms of profitability, PMI's ROE is +4.99%, compared to EW's ROE of +0.10%. Regarding short-term risk, PMI is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for PMI.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
PMI vs DXCM Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while DXCM trades at $84.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas DXCM's P/E ratio is 36.37. In terms of profitability, PMI's ROE is +4.99%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, PMI is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for PMI.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
PMI vs RMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while RMD trades at $211.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas RMD's P/E ratio is 19.68. In terms of profitability, PMI's ROE is +4.99%, compared to RMD's ROE of +0.24%. Regarding short-term risk, PMI is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
PMI vs PHG Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PHG trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PHG's P/E ratio is 15.28. In terms of profitability, PMI's ROE is +4.99%, compared to PHG's ROE of +0.10%. Regarding short-term risk, PMI is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
PMI vs ZBH Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ZBH trades at $96.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ZBH's P/E ratio is 11.38. In terms of profitability, PMI's ROE is +4.99%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, PMI is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
PMI vs ABMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ABMD's P/E ratio is 65.36. In terms of profitability, PMI's ROE is +4.99%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, PMI is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
PMI vs PEN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PEN trades at $324.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PEN's P/E ratio is 84.77. In terms of profitability, PMI's ROE is +4.99%, compared to PEN's ROE of +0.11%. Regarding short-term risk, PMI is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
PMI vs SNN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SNN's P/E ratio is 14.16. In terms of profitability, PMI's ROE is +4.99%, compared to SNN's ROE of +0.12%. Regarding short-term risk, PMI is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
PMI vs SWAV Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SWAV's P/E ratio is 78.76. In terms of profitability, PMI's ROE is +4.99%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, PMI is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
PMI vs ALGN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ALGN trades at $173.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ALGN's P/E ratio is 15.83. In terms of profitability, PMI's ROE is +4.99%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, PMI is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
PMI vs GMED Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while GMED trades at $82.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas GMED's P/E ratio is 18.56. In terms of profitability, PMI's ROE is +4.99%, compared to GMED's ROE of +0.12%. Regarding short-term risk, PMI is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for PMI.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
PMI vs GKOS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while GKOS trades at $180.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas GKOS's P/E ratio is -209.45. In terms of profitability, PMI's ROE is +4.99%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, PMI is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for PMI.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
PMI vs PODD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PODD trades at $141.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PODD's P/E ratio is 24.05. In terms of profitability, PMI's ROE is +4.99%, compared to PODD's ROE of +0.27%. Regarding short-term risk, PMI is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
PMI vs BIO-B Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, PMI's ROE is +4.99%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, PMI is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
PMI vs BIO Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BIO trades at $352.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BIO's P/E ratio is 38.00. In terms of profitability, PMI's ROE is +4.99%, compared to BIO's ROE of +0.03%. Regarding short-term risk, PMI is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
PMI vs MASI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas MASI's P/E ratio is 44.43. In terms of profitability, PMI's ROE is +4.99%, compared to MASI's ROE of +0.09%. Regarding short-term risk, PMI is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for PMI.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
PMI vs BRKR Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BRKR trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BRKR's P/E ratio is 26.84. In terms of profitability, PMI's ROE is +4.99%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, PMI is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
PMI vs NARI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas NARI's P/E ratio is -59.24. In terms of profitability, PMI's ROE is +4.99%, compared to NARI's ROE of -0.00%. Regarding short-term risk, PMI is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for PMI.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
PMI vs ITGR Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ITGR trades at $125.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ITGR's P/E ratio is 19.72. In terms of profitability, PMI's ROE is +4.99%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, PMI is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
PMI vs IRTC Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while IRTC trades at $127.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas IRTC's P/E ratio is -199.75. In terms of profitability, PMI's ROE is +4.99%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, PMI is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for PMI.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
PMI vs LIVN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while LIVN trades at $76.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas LIVN's P/E ratio is 18.10. In terms of profitability, PMI's ROE is +4.99%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, PMI is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
PMI vs HAE Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, HAE has a market cap of 4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while HAE trades at $87.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas HAE's P/E ratio is 17.54. In terms of profitability, PMI's ROE is +4.99%, compared to HAE's ROE of +0.11%. Regarding short-term risk, PMI is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for PMI.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
PMI vs AXNX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AXNX's P/E ratio is -709.80. In terms of profitability, PMI's ROE is +4.99%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, PMI is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
PMI vs TMDX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while TMDX trades at $83.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas TMDX's P/E ratio is 42.58. In terms of profitability, PMI's ROE is +4.99%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, PMI is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
PMI vs AXGN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AXGN trades at $46.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AXGN's P/E ratio is 122.18. In terms of profitability, PMI's ROE is +4.99%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, PMI is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
PMI vs UFPT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while UFPT trades at $314.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas UFPT's P/E ratio is 32.07. In terms of profitability, PMI's ROE is +4.99%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, PMI is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
PMI vs BFLY Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BFLY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BFLY's P/E ratio is -36.77. In terms of profitability, PMI's ROE is +4.99%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, PMI is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
PMI vs ESTA Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ESTA trades at $77.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ESTA's P/E ratio is -61.44. In terms of profitability, PMI's ROE is +4.99%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, PMI is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
PMI vs NUVA Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas NUVA's P/E ratio is 75.00. In terms of profitability, PMI's ROE is +4.99%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, PMI is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for PMI.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
PMI vs NVCR Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while NVCR trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas NVCR's P/E ratio is -10.71. In terms of profitability, PMI's ROE is +4.99%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, PMI is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for PMI.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
PMI vs INSP Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while INSP trades at $60.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas INSP's P/E ratio is 26.51. In terms of profitability, PMI's ROE is +4.99%, compared to INSP's ROE of +0.18%. Regarding short-term risk, PMI is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for PMI.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
PMI vs TNDM Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while TNDM trades at $22.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas TNDM's P/E ratio is -20.35. In terms of profitability, PMI's ROE is +4.99%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, PMI is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for PMI.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
PMI vs ENOV Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ENOV trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ENOV's P/E ratio is 7.62. In terms of profitability, PMI's ROE is +4.99%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, PMI is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
PMI vs CNMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CNMD trades at $49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CNMD's P/E ratio is 10.78. In terms of profitability, PMI's ROE is +4.99%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, PMI is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
PMI vs ATEC Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ATEC trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ATEC's P/E ratio is -155.17. In terms of profitability, PMI's ROE is +4.99%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, PMI is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
PMI vs IART Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while IART trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas IART's P/E ratio is 7.31. In terms of profitability, PMI's ROE is +4.99%, compared to IART's ROE of -0.01%. Regarding short-term risk, PMI is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for PMI.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
PMI vs AORT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AORT trades at $27.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AORT's P/E ratio is 45.28. In terms of profitability, PMI's ROE is +4.99%, compared to AORT's ROE of -0.01%. Regarding short-term risk, PMI is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
PMI vs HSKA Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas HSKA's P/E ratio is -62.49. In terms of profitability, PMI's ROE is +4.99%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, PMI is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for PMI.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
PMI vs IRMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while IRMD trades at $92.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas IRMD's P/E ratio is 46.48. In terms of profitability, PMI's ROE is +4.99%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, PMI is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
PMI vs AVNS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AVNS's P/E ratio is 27.77. In terms of profitability, PMI's ROE is +4.99%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, PMI is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
PMI vs PRCT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PRCT trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PRCT's P/E ratio is -10.52. In terms of profitability, PMI's ROE is +4.99%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, PMI is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
PMI vs SILK Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SILK's P/E ratio is -18.96. In terms of profitability, PMI's ROE is +4.99%, compared to SILK's ROE of -0.35%. Regarding short-term risk, PMI is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
PMI vs LMRI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while LMRI trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas LMRI's P/E ratio is -22.53. In terms of profitability, PMI's ROE is +4.99%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, PMI is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for PMI.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
PMI vs FNA Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas FNA's P/E ratio is -19.83. In terms of profitability, PMI's ROE is +4.99%, compared to FNA's ROE of -0.35%. Regarding short-term risk, PMI is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for PMI.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
PMI vs BVS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BVS trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BVS's P/E ratio is 18.59. In terms of profitability, PMI's ROE is +4.99%, compared to BVS's ROE of +0.28%. Regarding short-term risk, PMI is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
PMI vs INMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, INMD has a market cap of 880M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while INMD trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas INMD's P/E ratio is 10.63. In terms of profitability, PMI's ROE is +4.99%, compared to INMD's ROE of +0.13%. Regarding short-term risk, PMI is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
PMI vs AVR Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AVR trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AVR's P/E ratio is -4.00. In terms of profitability, PMI's ROE is +4.99%, compared to AVR's ROE of -1.24%. Regarding short-term risk, PMI is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
PMI vs CSII Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CSII's P/E ratio is -20.83. In terms of profitability, PMI's ROE is +4.99%, compared to CSII's ROE of -0.14%. Regarding short-term risk, PMI is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
PMI vs SIBN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SIBN trades at $18.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SIBN's P/E ratio is -54.74. In terms of profitability, PMI's ROE is +4.99%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, PMI is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
PMI vs AHCO Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while AHCO trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas AHCO's P/E ratio is 11.61. In terms of profitability, PMI's ROE is +4.99%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, PMI is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for PMI.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
PMI vs SSII Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SSII trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SSII's P/E ratio is -73.53. In terms of profitability, PMI's ROE is +4.99%, compared to SSII's ROE of -0.23%. Regarding short-term risk, PMI is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
PMI vs BBNX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BBNX trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BBNX's P/E ratio is -10.53. In terms of profitability, PMI's ROE is +4.99%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, PMI is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for PMI.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
PMI vs CBLL Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CBLL trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CBLL's P/E ratio is -11.54. In terms of profitability, PMI's ROE is +4.99%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, PMI is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
PMI vs TCMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, TCMD has a market cap of 665.4M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while TCMD trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas TCMD's P/E ratio is 33.52. In terms of profitability, PMI's ROE is +4.99%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, PMI is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
PMI vs SRDX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SRDX's P/E ratio is -34.66. In terms of profitability, PMI's ROE is +4.99%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, PMI is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
PMI vs BWAY Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BWAY trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BWAY's P/E ratio is 39.38. In terms of profitability, PMI's ROE is +4.99%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, PMI is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for PMI.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
PMI vs KIDS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, KIDS has a market cap of 584.8M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while KIDS trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas KIDS's P/E ratio is -19.30. In terms of profitability, PMI's ROE is +4.99%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, PMI is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for PMI.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
PMI vs APEN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas APEN's P/E ratio is -9.43. In terms of profitability, PMI's ROE is +4.99%, compared to APEN's ROE of -0.85%. Regarding short-term risk, PMI is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
PMI vs CTKB Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CTKB trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CTKB's P/E ratio is -22.25. In terms of profitability, PMI's ROE is +4.99%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, PMI is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
PMI vs ZIMV Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, PMI's ROE is +4.99%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, PMI is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
PMI vs VREX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while VREX trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas VREX's P/E ratio is 13.06. In terms of profitability, PMI's ROE is +4.99%, compared to VREX's ROE of -0.18%. Regarding short-term risk, PMI is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
PMI vs DCTH Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, DCTH has a market cap of 521.6M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while DCTH trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas DCTH's P/E ratio is 1511.00. In terms of profitability, PMI's ROE is +4.99%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, PMI is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for PMI.Check DCTH's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
PMI vs NPCE Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while NPCE trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas NPCE's P/E ratio is -25.57. In terms of profitability, PMI's ROE is +4.99%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, PMI is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for PMI.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
PMI vs CERS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CERS trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CERS's P/E ratio is -46.91. In terms of profitability, PMI's ROE is +4.99%, compared to CERS's ROE of -0.10%. Regarding short-term risk, PMI is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
PMI vs CLPT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CLPT trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CLPT's P/E ratio is -12.04. In terms of profitability, PMI's ROE is +4.99%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, PMI is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
PMI vs OFIX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while OFIX trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas OFIX's P/E ratio is -13.43. In terms of profitability, PMI's ROE is +4.99%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, PMI is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
PMI vs SGHT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SGHT trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SGHT's P/E ratio is -13.34. In terms of profitability, PMI's ROE is +4.99%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, PMI is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
PMI vs CARL Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CARL trades at $13.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CARL's P/E ratio is -9.66. In terms of profitability, PMI's ROE is +4.99%, compared to CARL's ROE of -0.38%. Regarding short-term risk, PMI is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
PMI vs PACB Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PACB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PACB's P/E ratio is -2.89. In terms of profitability, PMI's ROE is +4.99%, compared to PACB's ROE of -49.62%. Regarding short-term risk, PMI is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
PMI vs CV Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CV trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CV's P/E ratio is -2.84. In terms of profitability, PMI's ROE is +4.99%, compared to CV's ROE of +1.27%. Regarding short-term risk, PMI is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CV's competition here
Electromed, Inc. (AMEX: ELMD)
PMI vs ELMD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ELMD trades at $42.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ELMD's P/E ratio is 35.97. In terms of profitability, PMI's ROE is +4.99%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, PMI is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
PMI vs CATX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while CATX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas CATX's P/E ratio is -2.13. In terms of profitability, PMI's ROE is +4.99%, compared to CATX's ROE of -0.42%. Regarding short-term risk, PMI is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
PMI vs SMLR Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SMLR's P/E ratio is 3.92. In terms of profitability, PMI's ROE is +4.99%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, PMI is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for PMI.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
PMI vs TMCI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while TMCI trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas TMCI's P/E ratio is -5.06. In terms of profitability, PMI's ROE is +4.99%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, PMI is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for PMI.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
PMI vs SENS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while SENS trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas SENS's P/E ratio is -3.51. In terms of profitability, PMI's ROE is +4.99%, compared to SENS's ROE of -1.66%. Regarding short-term risk, PMI is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for PMI.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
PMI vs ANIK Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ANIK trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ANIK's P/E ratio is 43.71. In terms of profitability, PMI's ROE is +4.99%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, PMI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
PMI vs PROF Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while PROF trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas PROF's P/E ratio is -5.98. In terms of profitability, PMI's ROE is +4.99%, compared to PROF's ROE of -0.56%. Regarding short-term risk, PMI is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for PMI.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
PMI vs RXST Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while RXST trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas RXST's P/E ratio is -6.73. In terms of profitability, PMI's ROE is +4.99%, compared to RXST's ROE of -0.17%. Regarding short-term risk, PMI is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for PMI.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
PMI vs MGRM Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas MGRM's P/E ratio is -12.00. In terms of profitability, PMI's ROE is +4.99%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, PMI is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for PMI.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
PMI vs FOCL Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while FOCL trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas FOCL's P/E ratio is -8.00. In terms of profitability, PMI's ROE is +4.99%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, PMI is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for PMI.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
PMI vs NVRO Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas NVRO's P/E ratio is -1.91. In terms of profitability, PMI's ROE is +4.99%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, PMI is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for PMI.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
PMI vs TLSI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while TLSI trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas TLSI's P/E ratio is -3.34. In terms of profitability, PMI's ROE is +4.99%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, PMI is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for PMI.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
PMI vs RCEL Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while RCEL trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas RCEL's P/E ratio is -4.95. In terms of profitability, PMI's ROE is +4.99%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, PMI is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for PMI.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
PMI vs BSGM Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas BSGM's P/E ratio is -5.81. In terms of profitability, PMI's ROE is +4.99%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, PMI is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for PMI.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
PMI vs QTRX Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while QTRX trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas QTRX's P/E ratio is -2.52. In terms of profitability, PMI's ROE is +4.99%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, PMI is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for PMI.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
PMI vs MDGS Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas MDGS's P/E ratio is -0.27. In terms of profitability, PMI's ROE is +4.99%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, PMI is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for PMI.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
PMI vs STIM Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while STIM trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas STIM's P/E ratio is -4.41. In terms of profitability, PMI's ROE is +4.99%, compared to STIM's ROE of -1.65%. Regarding short-term risk, PMI is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for PMI.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
PMI vs INGN Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while INGN trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas INGN's P/E ratio is -6.65. In terms of profitability, PMI's ROE is +4.99%, compared to INGN's ROE of -0.13%. Regarding short-term risk, PMI is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for PMI.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
PMI vs QIPT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas QIPT's P/E ratio is -15.87. In terms of profitability, PMI's ROE is +4.99%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, PMI is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
PMI vs ICAD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas ICAD's P/E ratio is -20.37. In terms of profitability, PMI's ROE is +4.99%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, PMI is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
PMI vs OWLT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while OWLT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas OWLT's P/E ratio is -39.43. In terms of profitability, PMI's ROE is +4.99%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, PMI is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
PMI vs LUCD Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while LUCD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas LUCD's P/E ratio is -2.61. In terms of profitability, PMI's ROE is +4.99%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, PMI is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for PMI.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
PMI vs HSDT Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas HSDT's P/E ratio is -0.02. In terms of profitability, PMI's ROE is +4.99%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, PMI is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for PMI.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
PMI vs HJLI Comparison August 2026
Picard Medical, Inc. (AMEX: PMI) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMI stands at 349.2M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, PMI is priced at $3.43 on the AMEX, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMI currently has a P/E ratio of -2.83, whereas HJLI's P/E ratio is N/A. In terms of profitability, PMI's ROE is +4.99%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, PMI is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for PMI.Check HJLI's competition here